Comparison of Interleukin-6, C-Reactive Protein, Procalcitonin, and the Computed Tomography Severity Index for Early Prediction of Severity of Acute Pancreatitis
Gut and Liver · 5 authors, 2 centres
AI SUMMARY
FIDELITY 100%
POPULATION103 patients hospitalized with acute pancreatitis
INTERVENTIONMeasurement of inflammatory markers (IL-6, CRP, procalcitonin) and scoring systems (CTSI, BISAP, Ranson, APACHE II) at admission
COMPARISONMild acute pancreatitis versus more severe forms, defined by the revised Atlanta classification
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This retrospective study of 103 hospitalized patients compared inflammatory markers and scoring systems for early prediction of mild acute pancreatitis. It found that interleukin-6 (IL-6) measured at admission, C-reactive protein measured 24 hours after admission (CRP2), and the CT severity index (CTSI) were useful predictors.
Full summary
836 CHARS
This was a retrospective cohort study of 103 hospitalized patients with acute pancreatitis. The study aimed to compare the ability of inflammatory markers (IL-6, CRP, procalcitonin) and various scoring systems (CTSI, BISAP, Ranson, APACHE II) to predict mild disease severity at admission. The central finding was that IL-6 measured at admission, CRP measured 24 hours after admission, and the CTSI were useful predictors of mild acute pancreatitis, with AUROCs of 0.755, 0.787, and 0.851, respectively. The study concluded these markers are helpful for early differentiation. Limitations include the retrospective, single-center design and the lack of routine measurement for all patients, which may introduce bias. The implications are that these markers may aid in early clinical decision-making for patients with acute pancreatitis.
PICO
PPOPULATION
103 patients hospitalized with acute pancreatitis
IINTERVENTION
Measurement of inflammatory markers (IL-6, CRP, procalcitonin) and scoring systems (CTSI, BISAP, Ranson, APACHE II) at admission
OOUTCOME
Ability to differentiate mild from severe acute pancreatitis